Protein creatinine ratio (Spot)

Kidney

Report in 4Hrs

At Home

No Fasting Required

Details

Key marker of kidney filtration function (GFR); elevated in renal impairment.

₹249₹605

59% OFF

Protein Creatinine Ratio (Spot) - Comprehensive Medical Test Guide

Why is it done?
- Measures the amount of protein present in a single urine sample (spot urine) relative to creatinine levels to detect and monitor proteinuria (excess protein in urine)
- Screens for kidney disease and assesses kidney function in patients with diabetes, hypertension, or other risk factors for renal disease
- Monitors progression of chronic kidney disease and effectiveness of treatment in patients already diagnosed with kidney conditions
- Evaluates proteinuria in pregnant women to screen for preeclampsia and pregnancy-related kidney complications
- Diagnoses glomerulonephritis and other systemic diseases affecting the kidneys such as lupus and multiple myeloma
- Provides a convenient alternative to 24-hour urine collection, requiring only a single random or first-morning urine sample
Normal Range
- Normal/Reference Values: Less than 30 mg/g creatinine (or <3.4 mg/mmol)
- Microalbuminuria Range: 30-300 mg/g creatinine (or 3.4-34 mg/mmol)
- Macroalbuminuria/Nephrotic Range: Greater than 300 mg/g creatinine (or >34 mg/mmol)
- Units of Measurement: mg/g creatinine or mg/mmol creatinine; may also be expressed as g/g creatinine
- Interpretation:
  - Normal: <30 mg/g indicates no significant proteinuria; kidney function is preserved
  - Abnormal: Any value ≥30 mg/g indicates proteinuria and suggests kidney damage or disease requiring further evaluation
  - The ratio accounts for variations in urine concentration and hydration status, making spot urine collection more reliable than total protein measurement alone
Interpretation
- Low Values (<30 mg/g):
  - Indicates normal kidney function with no proteinuria; glomerular filtration barrier is intact
- Microalbuminuria Range (30-300 mg/g):
  - Early sign of kidney disease; particularly significant in diabetic patients as predictor of diabetic nephropathy
  - May indicate early hypertensive kidney disease, glomerulonephritis, or other renal pathology
  - Requires investigation and close monitoring; often warrants lifestyle modifications and/or pharmacological intervention
- Macroalbuminuria (>300 mg/g):
  - Indicates moderate to advanced kidney disease with significant glomerular damage
  - In diabetic patients, suggests established diabetic nephropathy with increased risk of progression to end-stage renal disease
  - Associated with increased cardiovascular risk and requires aggressive treatment
- Factors Affecting Results:
  - Acute illness, fever, or intense exercise may transiently elevate protein levels without indicating kidney disease
  - Hydration status and time of day can influence urine concentration; first-morning urine is preferred for standardization
  - Urinary tract infections may cause false positive results due to inflammatory proteins and bacteria
  - Menstruation or recent urological procedures can contaminate urine sample
  - Certain medications including NSAIDs and ACE inhibitors may transiently affect proteinuria levels
Associated Organs
- Primary Organ System:
  - Renal (kidney) system - specifically the glomeruli which filter waste and retain necessary proteins
- Diseases Associated with Abnormal Results:
  - Diabetic nephropathy - progressive kidney disease in patients with diabetes mellitus
  - Hypertensive nephrosclerosis - kidney damage from prolonged hypertension
  - Glomerulonephritis - inflammation of kidney glomeruli caused by infection or autoimmune disease
  - Systemic lupus erythematosus (SLE) - autoimmune disease affecting kidneys
  - Multiple myeloma - cancer causing plasma protein accumulation in kidneys
  - Nephrotic syndrome - collection of symptoms resulting from kidney damage with massive proteinuria
  - IgA nephropathy - immune complex kidney disease
  - Preeclampsia/Eclampsia - pregnancy-related hypertension with kidney involvement
  - Chronic kidney disease (CKD) - progressive loss of kidney function
  - Alport syndrome - inherited disorder affecting kidney basement membrane
- Complications Associated with Abnormal Results:
  - Progressive kidney failure leading to end-stage renal disease (ESRD) requiring dialysis or transplantation
  - Cardiovascular disease and stroke - proteinuria is independent risk factor
  - Anemia - from reduced erythropoietin production in failing kidneys
  - Hypoproteinemia - loss of serum proteins leading to edema and malnutrition
  - Bone disease - from altered mineral and vitamin D metabolism in chronic kidney disease
  - Hypertension - may worsen kidney disease in feedback cycle
Follow-up Tests
- If Results are Abnormal (≥30 mg/g):
  - Serum creatinine and blood urea nitrogen (BUN) - assess overall kidney function and glomerular filtration rate (GFR)
  - Estimated glomerular filtration rate (eGFR) - stage chronic kidney disease severity
  - 24-hour urine protein collection - confirm diagnosis and quantify total daily protein loss more accurately
  - Urinalysis with microscopy - identify casts, cells, and crystals indicating specific kidney pathology
  - Blood pressure monitoring - assess contribution of hypertension to kidney disease
  - Serum electrolytes (sodium, potassium, chloride, bicarbonate) - evaluate kidney function and acid-base status
  - Renal ultrasound or CT scan - assess kidney size, structure, and exclude obstruction
  - Kidney biopsy - if diagnosis remains unclear after initial workup, particularly if rapid decline in function
- Specialized Testing if Systemic Disease Suspected:
  - Antinuclear antibody (ANA) - screen for lupus and other autoimmune diseases
  - Complement levels (C3, C4) - evaluate immune complex deposition in glomerulonephritis
  - Serum and urine protein electrophoresis - assess for monoclonal proteins in multiple myeloma
  - ANCA (antineutrophil cytoplasmic antibodies) - screen for vasculitis
- Monitoring Frequency:
  - Microalbuminuria: Repeat testing every 3-6 months to track progression and response to therapy
  - Macroalbuminuria: More frequent monitoring (every 1-3 months) as disease progression is more likely
  - Diabetic patients without proteinuria: Annual screening recommended to detect early microalbuminuria
  - Post-treatment monitoring: Test 3-6 months after initiating ACE inhibitors or ARBs to assess therapeutic response
Fasting Required?
- Fasting Required:No
- Sample Collection:
  - Spot (random) urine sample collected at any time of day into a clean container
  - First-morning urine preferred for standardization as it is most concentrated
  - Can be collected at home or in laboratory without prior preparation
- Patient Preparation Instructions:
  - No special diet restrictions - may eat and drink normally
  - Drink adequate water on day of collection to ensure sufficient urine production
  - If female, avoid collection during menstruation as blood can interfere with test results
  - Genital area should be cleaned thoroughly with antiseptic wipe before collecting midstream urine sample
  - Use sterile or clean container for collection to prevent contamination
- Medications and Supplements:
  - Continue all regular medications unless specifically instructed otherwise by physician
  - Inform healthcare provider of recent NSAIDs, ACE inhibitors, ARBs, or other medications affecting kidney function
  - Avoid strenuous exercise or fever-inducing activities 24 hours before test to prevent falsely elevated results
  - Wait at least 7-14 days after acute illness before test if possible, as infection can cause transient proteinuria

How our test process works!